Van ECK Associates Corp increased its stake in Trinity Capital Inc. (NASDAQ:TRIN – Free Report) by 14.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,746,217 shares of the company’s stock after purchasing an additional 225,814 shares during the period. Van ECK Associates Corp owned approximately 2.31% of Trinity Capital worth $27,032,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently added to or reduced their stakes in TRIN. SMH Capital Advisors Inc. raised its stake in shares of Trinity Capital by 2.6% in the 3rd quarter. SMH Capital Advisors Inc. now owns 138,961 shares of the company’s stock valued at $2,097,000 after purchasing an additional 3,476 shares during the period. Private Advisor Group LLC grew its holdings in shares of Trinity Capital by 7.8% during the third quarter. Private Advisor Group LLC now owns 28,549 shares of the company’s stock worth $442,000 after buying an additional 2,071 shares in the last quarter. Prevail Innovative Wealth Advisors LLC bought a new position in shares of Trinity Capital during the third quarter worth about $1,959,000. Melia Wealth LLC raised its position in Trinity Capital by 2.6% in the 3rd quarter. Melia Wealth LLC now owns 1,179,296 shares of the company’s stock valued at $18,256,000 after buying an additional 30,360 shares during the last quarter. Finally, Denali Advisors LLC raised its position in Trinity Capital by 2.9% in the 3rd quarter. Denali Advisors LLC now owns 105,472 shares of the company’s stock valued at $1,633,000 after buying an additional 2,942 shares during the last quarter. Institutional investors own 24.62% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on TRIN. Citizens Jmp set a $17.50 price target on shares of Trinity Capital in a research note on Monday, December 8th. Noble Financial initiated coverage on shares of Trinity Capital in a report on Thursday, December 11th. They set a “buy” rating for the company. Loop Capital set a $17.00 target price on shares of Trinity Capital in a research report on Thursday, December 11th. Clear Str upgraded shares of Trinity Capital to a “strong-buy” rating in a research note on Wednesday, February 4th. Finally, Citigroup restated an “outperform” rating on shares of Trinity Capital in a research note on Tuesday, January 27th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $16.29.
Key Trinity Capital News
Here are the key news stories impacting Trinity Capital this week:
- Positive Sentiment: Trinity committed $35 million in growth capital to Neuros Medical, expanding its MedTech portfolio and potential interest/fee income as Neuros scales adoption of its FDA‑approved therapy. Trinity Capital Inc. Provides $35 Million in Growth Capital to Neuros Medical, Inc. to Scale Pain Management Therapy Adoption
- Positive Sentiment: Trinity provided $20 million to Emboline to support commercialization of the Emboliner embolic protection system — another MedTech deployment that should grow Trinity’s asset base and future yield. Trinity Capital Inc. Provides $20 Million in Growth Capital to Emboline, Inc. to Advance Interventional Heart Procedure Technology
- Positive Sentiment: Insiders increased holdings: Chairman Steve L. Brown and Director Ronald E. Estes purchased shares in recent filings, a common signal of management confidence in the company’s outlook. SEC Ownership Filing
- Neutral Sentiment: An analysis contrasting Trinity with Chicago Atlantic BDC provides comparative context for investors evaluating BDC positioning and valuation, but contains no company-specific catalysts. Contrasting Chicago Atlantic BDC (NASDAQ:LIEN) and Trinity Capital (NASDAQ:TRIN)
- Negative Sentiment: A Seeking Alpha piece highlights a rating downgrade on TRINZ 7.875% Notes due 2029 and expects those notes may be called as Trinity pivots to cheaper secured funding — this raises short‑term refinancing and credit‑cost concerns for some investors. TRINZ: To Refi Or Not To Refi (Rating Downgrade)
Insider Buying and Selling at Trinity Capital
In other Trinity Capital news, CEO Kyle Steven Brown purchased 3,333 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were acquired at an average price of $14.90 per share, for a total transaction of $49,661.70. Following the purchase, the chief executive officer owned 376,775 shares in the company, valued at approximately $5,613,947.50. The trade was a 0.89% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Over the last quarter, insiders purchased 7,741 shares of company stock worth $115,358. 5.31% of the stock is currently owned by insiders.
Trinity Capital Trading Down 0.6%
Shares of TRIN opened at $14.80 on Thursday. The company has a market cap of $1.23 billion, a price-to-earnings ratio of 7.55 and a beta of 0.55. The company’s fifty day simple moving average is $15.71 and its 200 day simple moving average is $15.41. Trinity Capital Inc. has a 1-year low of $12.50 and a 1-year high of $17.20.
Trinity Capital (NASDAQ:TRIN – Get Free Report) last issued its earnings results on Wednesday, February 25th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.01. The company had revenue of $58.89 million for the quarter, compared to analysts’ expectations of $79.83 million. Trinity Capital had a net margin of 46.18% and a return on equity of 14.97%. As a group, research analysts forecast that Trinity Capital Inc. will post 2.06 earnings per share for the current year.
Trinity Capital Announces Dividend
The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 13th will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Friday, March 13th. This represents a c) dividend on an annualized basis and a dividend yield of 13.8%. Trinity Capital’s payout ratio is presently 104.08%.
About Trinity Capital
Trinity Capital Corporation (NASDAQ: TRIN) is a publicly traded business development company that provides flexible financing solutions to venture-backed and growth-stage companies. As a venture lender, Trinity Capital offers customized capital structures, including secured debt and equity co-investment, designed to support companies that have progressed beyond early-stage funding but still require non-dilutive growth capital.
The company focuses its investments on technology-driven sectors such as software, fintech, healthcare, life sciences and cleantech.
Further Reading
- Five stocks we like better than Trinity Capital
- “This AI Giant is About to Go Bust”
- Is Trump Done? Shocking leak…
- The gold chart Wall Street is terrified of…
- I tried out Elon Musk’s new AI tech — it floored me
- Only 500 people today…
Receive News & Ratings for Trinity Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trinity Capital and related companies with MarketBeat.com's FREE daily email newsletter.
